“…Chloride channel regulators, calcium activated ( CLCA ) constitute a family of genes that has been correlated to various disease conditions, including chronic inflammatory airway diseases ( Hoshino et al, 2002 ; Nakanishi et al, 2001 ; Patel, Brett & Holtzman, 2009 ; Range, Mundhenk & Gruber, 2007 ), cystic fibrosis ( Hauber et al, 2003 ; Ritzka et al, 2004 ; Young et al, 2007 ) and cancer ( Chen et al, 2019 ; Hou et al, 2017 ; Walia et al, 2009 ; Walia et al, 2012 ; Yu, Walia & Elble, 2013 ) and shows striking evolutionary dynamics ( Bartenschlager et al, 2022 ; Mundhenk et al, 2018 ). In general, CLCAs comprise a prototypical protein domain architecture of a CLCA N-terminal (N-CLCA), a von Willebrand factor type A (vWA), a beta sheet rich (bsr) as well as a carboxy (C)-terminal fibronectin type III domain (fn3) that is separated from N-CLCA, vWA and bsr by proteolytical cleavage ( Patel, Brett & Holtzman, 2009 ).…”